Karachi: AGP Limited has announced that its Board of Directors has authorized the company to pursue strategic growth initiatives, including the evaluation of potential acquisitions, investments, and business combinations, as part of its long-term expansion strategy.
According to a material information notice submitted to the Pakistan Stock Exchange (PSX), the decision was taken during a Board meeting held on April 29, 2026, at the company’s registered office. The Board has directed the management to identify and assess opportunities that can strengthen AGP’s market position while enhancing operational efficiency and creating long-term value for shareholders.
The company stated that, alongside exploring mergers, acquisitions, and investment opportunities, it will also focus on initiatives aimed at optimizing operations, realizing synergies across its businesses, and improving overall organizational performance.
To advance these plans, AGP will undertake detailed feasibility studies, commercial evaluations, and valuation analyses before presenting actionable proposals to the Board for consideration and approval. This structured approach is intended to ensure that any strategic transaction aligns with the company’s growth objectives and financial priorities.
The Board has also authorized the appointment of legal, financial, and other professional advisors or consultants to assist in evaluating and executing potential opportunities as required.
The announcement underscores AGP’s commitment to expanding its business portfolio and capitalizing on growth opportunities in the healthcare and pharmaceutical sector while maintaining a disciplined approach to strategic investments. Investors are expected to closely monitor future developments as the company evaluates potential transactions that could shape its next phase of growth.
